Trump plans generic drug tariffs from 2028 with two-year delay testing U.S. onshoring push
The latest tariff salvo underscored Trump’s goal of reshoring low-cost drug production, but displacing established suppliers like India won’t be easy.
CNBC Daily Open: AI race, potential tariffs and Middle East conflict continue to heat up
The U.S.-China AI race continues to intensify amid signs that the Trump administration could sanction China over “theft,” while OpenAI ramps up IPO efforts.
Japan exports and imports in June grow at fastest pace since November 2022, beating estimates
Exports climbed 19.3%, while imports spiked 25.4% compared to June last year.
Sony’s ‘ironic’ PlayStation disc decision upends gamer conventions and threatens a $7 billion resale market
In 2013, Sony tweaked Xbox by showing how easy it was to share a PlayStation disc. Now, gamers say Sony has become exactly what it mocked.
Nike to cut off thousands of online distributors in China, restructure digital footprint
Nike is streamlining its online business in China as the company looks to stabilize pricing and branding and get back to growth.
Wall Street can wait: Why one U.S. biotech firm is listing in Hong Kong first
Global biotech firms are increasingly being drawn to Hong Kong for its growing investor base and proximity to Chinese pharmaceutical partners.
The world’s top fintech companies: 2026
Fintech is entering an era of scale and maturity, just as AI forces innovation. CNBC and Statista name the key players shaping the industry — and shaking it up.
The Fed rang the alarm about Anthropic’s Mythos AI model — but had to go months without it
The central bank didn’t have access to Claude Mythos Preview as of mid-July, even as other institutions were racing to patch their vulnerabilities.
Stock futures are little changed as investors gear up for more earnings: Live updates
Investors looked ahead to another busy day of corporate earnings, with several major technology and industrial companies set to report.
OpenAI appoints two new members to board of directors
OpenAI appointed longtime financial executives David Vélez and Robin Vince to its nonprofit and for-profit boards.
